Virbac Chooses Paul Hays To Head U.S. Commercial Operations

Posted: Dec. 18, 2012, 12:30 p.m. EST



Published:

Paul Hays will start Jan. 1 as president of U.S. commercial operations for Virbac Corp.

Former Pfizer Animal Health executive Paul Hays was named president Monday of Virbac Corp.’s U.S. commercial operations.

Hays will oversee sales, marketing, communications and technical services as well as brand management, customer relations and business planning.

Fort Worth, Texas-based Virbac Animal Health manufactures an array of pharmaceutical products for cats, dogs, equine and farm animals, including the heartworm preventive Iverhart, the dermatological shampoo Dermazole and the antibiotic Biomox.

Many Virbac products are sold exclusively through veterinarians.

Hays worked as vice president of global diagnostics at Pfizer Animal Health since 2011, after his previous employer, Synbiotics Corp., where he served as CEO and president, was purchased by Pfizer.

Before joining Synbiotics, Hays was an executive at Boehringer Ingelheim Vetmedica Inc., where he last served as executive vice president of U.S. business operations.

Hays will report to Erik Martinez, CEO of Virbac North America.

“Paul is a seasoned executive and a proven strategic leader with vast experience in managing pharmaceutical businesses, serving both U.S. and global customers and bringing products to market,” Martinez said. “Along with his animal health experience, this makes Paul the perfect leader to reinforce Virbac’s passion for animals and continue Virbac’s legacy of supporting both our veterinarian customers and pet owners.”

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Virginia Tech Holds Inaugural Veterinary Medicine Science Camp

The week-long camp was part of a pilot program to create opportunities for students from underrepresented populations interested in a veterinary career.

University of Guelph Professor Receives Terry Fox Grant

The grant will go toward testing an innovative vaccine in a canine osteosarcoma clinical trial.

Favorite Vet Contest Called Off Due to Bullying

The issue of cat declawing sparks controversy and the harassment of contest finalists.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module
Edit Module